Polymeric nanoparticles of FMISO: are nano-radiopharmaceuticals better than conventional ones?
Related Experiment Video
Updated: May 21, 2026

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging
Published on: November 20, 2018
Marta de Souza Albernaz1, Beatriz Ferreira de Carvalho Patricio, Gilberto Weissmuller
1Laboratory of Nanoradiopharmaceuticals – Rio de Janeiro – Brazil.
Abstract:
Nanotechnology has been the last frontier in the diagnoses and treatment of many diseases, especially in oncology. The use of nanoparticles of radiopharmaceuticals may represent the future of Nuclear Medicine. In this study we developed, characterized and tested polymeric nanoparticles of FMISO (fluoromisonidazole) in a dynamic study of biodistribution. The results of the development as characterization showed that nanoparticles were well obtained with a size range of 300- 500 nm and a spherical shape.

